glp 1 and abdominal pain 💬 We want to hear from you Have you or someone you know experienced severe stomach that radiated to your back when taking a GLP-1 medicine such as Ozempic, Wegovy or lower abdominal pain glp 1

M., & Colditz, G

Gastrointestinal adverse events - predominantly nausea, vomiting, diarrhea, and constipation - are the most common class effects, occurring in 20%-60% of patients depending on the agent and dose, and are typically of mild-to-moderate severity, dose-dependent, and most prominent during titration

Pettus J, Reeds D, Cavaiola TS et al (2018) Effect of a glucagon receptor antibody (REMD-477) in type 1 diabetes: A randomized controlled trial

In: Applied Therapeutics

Tirzepatide is a GLP-1 dual agonist that activates two receptors to treat type 2 diabetes and promote weight loss

Fan H, Gong N, Li TF, Ma AN, Wu XY, Wang MW et al (2015) The non-peptide GLP-1 receptor agonist WB4-24 blocks inflammatory nociception by stimulating -endorphin release from spinal microglia